Lymphoma, Low-Grade Completed Phase 2 Trials for Ibritumomab tiuxetan (DB00078)
Also known as: Low-Grade Lymphoma
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029914 (Lymphoma, Low-Grade) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00220285 | Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma | Treatment |